𝛼SK or Searchbearish
StubWorld: WuXi Biologics (2269 HK)'s Double Discounts; Melco (200 HK) Further Out Of Whack
551 Views19 Jan 2026 11:09
WuXi XDC Cayman (2268 HK)'s Offer for BioDlink International (1875 HK) will add an additional discount layer to WuXi Biologics (2269 HK). Plus Melco's NAV premium is unsustainable.
What is covered in the Full Insight:
- Introduction to Offer by WuXi XDC
- Analysis of WuXi Bio's Market Position
- Short Interest Overview of WuXi Bio and WuXi XDC
- Analysis of Melco's Trading Position
- Conclusion and Trading Recommendations
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- StubWorld: WuXi Biologics (2269 HK)'s Double Discounts; Melco (200 HK) Further Out Of Whack19 Jan 2026
- BioDlink (1875 HK): WuXi XDC's Clean VGO15 Jan 2026
- StubWorld: Melco (200 HK) Looking Toppish. Again.30 Sep 2025
x